引用本文: | 冯卫能, 邓秋梅. 厄洛替尼联合抗血管生成药物对比厄洛替尼单药一线治疗EGFR突变晚期非小细胞肺癌的疗效[J]. 循证医学, 2020, 20(1): 53-57. DOI: 10.12019/j.issn.1671-5144.2020.01.012 |
Citation: | FENG Wei-neng, DENG Qiu-mei. The Efficacy of Erlotinib Combined with Anti-Angiogenesis Treatment in Comparison with Erlotinib Alone as First-Line Treatment of EGFR-Mutated Advanced Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2020, 20(1): 53-57. DOI: 10.12019/j.issn.1671-5144.2020.01.012 |